145 related articles for article (PubMed ID: 12137805)
1. Placental cytochrome P450scc (CYP11A1): comparison of catalytic properties between conditions of limiting and saturating adrenodoxin reductase.
Tuckey RC; Headlam MJ
J Steroid Biochem Mol Biol; 2002 Jun; 81(2):153-8. PubMed ID: 12137805
[TBL] [Abstract][Full Text] [Related]
2. The concentration of adrenodoxin reductase limits cytochrome p450scc activity in the human placenta.
Tuckey RC; Sadleir J
Eur J Biochem; 1999 Jul; 263(2):319-25. PubMed ID: 10406938
[TBL] [Abstract][Full Text] [Related]
3. Oxidized adrenodoxin acts as a competitive inhibitor of cytochrome P450scc in mitochondria from the human placenta.
Tuckey RC; McKinley AJ; Headlam MJ
Eur J Biochem; 2001 Apr; 268(8):2338-43. PubMed ID: 11298752
[TBL] [Abstract][Full Text] [Related]
4. Electron transfer to cytochrome P-450scc limits cholesterol-side-chain-cleavage activity in the human placenta.
Tuckey RC; Woods ST; Tajbakhsh M
Eur J Biochem; 1997 Mar; 244(3):835-9. PubMed ID: 9108254
[TBL] [Abstract][Full Text] [Related]
5. Analysis of In Vivo Activity of the Bovine Cholesterol Hydroxylase/Lyase System Proteins Expressed in Escherichia coli.
Efimova VS; Isaeva LV; Rubtsov MA; Novikova LA
Mol Biotechnol; 2019 Apr; 61(4):261-273. PubMed ID: 30729436
[TBL] [Abstract][Full Text] [Related]
6. Progesterone synthesis by the human placenta.
Tuckey RC
Placenta; 2005 Apr; 26(4):273-81. PubMed ID: 15823613
[TBL] [Abstract][Full Text] [Related]
7. Role of positively charged residues lys267, lys270, and arg411 of cytochrome p450scc (CYP11A1) in interaction with adrenodoxin.
Strushkevich NV; Azeva TN; Lepesheva GI; Usanov SA
Biochemistry (Mosc); 2005 Jun; 70(6):664-71. PubMed ID: 16038609
[TBL] [Abstract][Full Text] [Related]
8. Electron leakage from the mitochondrial NADPH-adrenodoxin reductase-adrenodoxin-P450scc (cholesterol side chain cleavage) system.
Hanukoglu I; Rapoport R; Weiner L; Sklan D
Arch Biochem Biophys; 1993 Sep; 305(2):489-98. PubMed ID: 8396893
[TBL] [Abstract][Full Text] [Related]
9. Polycistronic expression of the mitochondrial steroidogenic P450scc system in the HEK293T cell line.
Efimova VS; Isaeva LV; Labudina AA; Tashlitsky VN; Rubtsov MA; Novikova LA
J Cell Biochem; 2019 Mar; 120(3):3124-3136. PubMed ID: 30272820
[TBL] [Abstract][Full Text] [Related]
10. Competition for electron transfer between cytochromes P450scc and P45011 beta in rat adrenal mitochondria.
Yamazaki T; McNamara BC; Jefcoate CR
Mol Cell Endocrinol; 1993 Sep; 95(1-2):1-11. PubMed ID: 8243798
[TBL] [Abstract][Full Text] [Related]
11. Interaction of catalytic domains in cytochrome P450scc--adrenodoxin reductase--adrenodoxin fusion protein imported into yeast mitochondria.
Novikova LA; Nazarov PA; Saveliev AS; Drutsa VL; Sergeev VN; Miller WL; Luzikov VN
Biochemistry (Mosc); 2000 Dec; 65(12):1362-6. PubMed ID: 11173506
[TBL] [Abstract][Full Text] [Related]
12. Comparative structural and immunochemical characterization of recombinant and natural cytochrome p450scc (CYPXIAI).
Lepesheva GI; Usanov SA
Biochemistry (Mosc); 1998 Feb; 63(2):224-34. PubMed ID: 9526119
[TBL] [Abstract][Full Text] [Related]
13. Paraquat inhibits progesterone synthesis in human placental mitochondria.
Milczarek R; Sokołowska E; Rybakowska I; Kaletha K; Klimek J
Placenta; 2016 Jul; 43():41-6. PubMed ID: 27324098
[TBL] [Abstract][Full Text] [Related]
14. Complex formation in vesicle-reconstituted mitochondrial cytochrome P450 systems (CYP11A1 and CYP11B1) as evidenced by rotational diffusion experiments using EPR and ST-EPR.
Schwarz D; Chernogolov A; Kisselev P
Biochemistry; 1999 Jul; 38(29):9456-64. PubMed ID: 10413522
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical characterization of steroid hydroxylases of adrenocortical mitochondria. 1. Antibodies as inhibitors of cytochrome P450scc (CYP11A1) and P450(11 beta) (CYP11B1) activities.
Chernogolov AA; Usanov SA
Biochemistry (Mosc); 1997 Dec; 62(12):1375-84. PubMed ID: 9481871
[TBL] [Abstract][Full Text] [Related]
16. Regulation of proteins in the cholesterol side-chain cleavage system in JEG-3 and Y-1 cells.
Black SM; Szklarz GD; Harikrishna JA; Lin D; Wolf CR; Miller WL
Endocrinology; 1993 Feb; 132(2):539-45. PubMed ID: 8425475
[TBL] [Abstract][Full Text] [Related]
17. Formation and functioning of fused cholesterol side-chain cleavage enzymes.
Nazarov PA; Drutsa VL; Miller WL; Shkumatov VM; Luzikov VN; Novikova LA
DNA Cell Biol; 2003 Apr; 22(4):243-52. PubMed ID: 12823901
[TBL] [Abstract][Full Text] [Related]
18. Comparative structural-functional characterization of recombinant and natural adrenodoxin. Interaction with cytochrome P450scc.
Lepesheva GI; Azeva TN; Strushkevich NV; Adamovich TB; Cherkesova TS; Usanov SA
Biochemistry (Mosc); 1999 Sep; 64(9):1079-88. PubMed ID: 10521726
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and optical biosensor study of adrenodoxin mutant AdxS112W displaying an enhanced interaction towards the cholesterol side chain cleavage enzyme (CYP11A1).
Schiffler B; Zöllner A; Bernhardt R
Eur Biophys J; 2011 Dec; 40(12):1275-82. PubMed ID: 21526428
[TBL] [Abstract][Full Text] [Related]
20. Construction and function of fusion enzymes of the human cytochrome P450scc system.
Harikrishna JA; Black SM; Szklarz GD; Miller WL
DNA Cell Biol; 1993 Jun; 12(5):371-9. PubMed ID: 8517924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
